This comparison looks at two distinct growth companies that share a similar pattern of sharp price swings. Hims & Hers Health (HIMS) runs a direct-to-consumer telehealth platform, while The Trade Desk (TTD) leads in programmatic digital advertising. Both have pulled back significantly from earlier peaks yet delivered notable, news-driven rallies lately. For traders focused on relative performance and for investors weighing durable growth against headline risks, the differences in how these names respond to catalysts and fundamentals provide a clear illustration.
Hims & Hers Health delivers treatments for sexual health, hair loss, skincare, mental health, and weight loss to more than two million subscribers on a cash-pay basis. Weight-loss offerings, built around compounded GLP-1 medications, have been a key driver. Recent trading has centered on regulatory updates: the FDA ended shortages of certain GLP-1 drugs, which restricts compounding, and the FTC filed a complaint in mid-2026 that led to a securities class action. In response, HIMS shifted toward branded partnerships with major drugmakers, producing sharp one-day gains. Revenue growth stays in double digits, yet gross margins have narrowed and the company moved to operating losses while building working capital and favoring lower-margin products. Shares still sit well below prior highs. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The Trade Desk operates a self-service platform that helps brands and agencies plan, purchase, and measure digital ad campaigns across the open web, including connected TV and streaming. Its model produces high-margin recurring revenue linked to advertising spend. After a stretch of slower growth, the latest quarter showed beats on both revenue and EPS, with forward guidance exceeding expectations. The company also expanded a streaming partnership, authorized additional share repurchases, and brought back a co-founder to lead agentic AI efforts. Shares rose more than 20% following the report. Even so, TTD remains far from its 52-week high, and management notes that growth has not yet reached long-term targets.
The companies operate in very different spaces. HIMS competes in consumer healthcare, where expansion is solid but increasingly tied to pharma partnerships and subject to FDA and FTC oversight. Its main task is turning fast revenue growth into steadier, higher margins. TTD works in ad tech, benefiting from sticky relationships, strong retention, and solid cash generation, yet it faces a more mature growth path and risks from competition and AI shifts.
Both have recent catalysts. HIMS moves have followed partnership news and regulatory items that can change direction quickly. TTD momentum comes from an earnings and guidance beat, which tends to carry more weight. On financial footing, TTD reports positive EPS, adjusted EBITDA, and free cash flow, while HIMS has moved to operating losses and carries legal overhangs. Valuations for both have compressed sharply from historical levels.
Based on the factors at hand, Tickeron’s AI currently points toward TTD over HIMS. The earnings beat, above-consensus guidance, customer retention, positive cash flow, and buyback program form a more stable near-term setup. HIMS, by contrast, contends with regulatory questions, litigation, and margin pressure that offset its revenue gains. This reflects a probabilistic view of positioning rather than a firm forecast; trend consistency and earnings quality currently favor TTD, though both names carry notable volatility and event risk.
In my own research process, I often turn to Tickeron’s Trending AI Robots to see how top-performing automated strategies are currently positioned across volatile names like these. The page highlights only the strongest bots for prevailing conditions, covering a range of styles and timeframes, which helps put quantitative signals alongside the fundamental and catalyst analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for TTD turned positive on October 09, 2026. Looking at past instances where TTD's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TTD's RSI Indicator exited the oversold zone, 28 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
Following a +5.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where TTD advanced for three days, in 220 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Aroon Indicator entered an Uptrend today. In 119 of 168 cases where TTD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 67 cases where TTD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TTD as a result. In 69 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
TTD moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TTD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
TTD broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.375) is normal, around the industry mean (-1.802). P/E Ratio (0.154) is within average values for comparable stocks, (21.593). Projected Growth (PEG Ratio) (0.886) is also within normal values, averaging (1.501). Dividend Yield (0.000) settles around the average of (0.084) among similar stocks. P/S Ratio (2.329) is also within normal values, averaging (1.860).
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. TTD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TTD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of online advertising exchange
Industry AdvertisingMarketingServices